Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 163,629 | 131,544 | 132,394 | 299,500 | 341,523 |
| Marketable Securities | 124,392 | 167,294 | 169,519 | 44,548 | N/A |
| Receivables | 55,402 | 49,624 | 43,100 | 48,864 | 39,636 |
| Inventories | 66,875 | 65,731 | 69,502 | 48,154 | 49,369 |
| TOTAL | $422,315 | $424,821 | $425,622 | $454,020 | $443,859 |
| Non-Current Assets | |||||
| PPE Net | 17,415 | 15,588 | 15,549 | 13,682 | 7,844 |
| Intangibles | 40,749 | 42,826 | 43,807 | 14,475 | 14,629 |
| Other Non-Current Assets | 38,951 | 41,819 | 39,597 | 37,299 | 32,963 |
| TOTAL | $97,115 | $100,233 | $98,953 | $65,456 | $55,436 |
| Total Assets | $519,430 | $525,054 | $524,575 | $519,476 | $499,295 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,711 | 3,082 | 5,280 | 4,805 | 5,640 |
| Accrued Expenses | 20,514 | 19,591 | 20,366 | 21,126 | 16,637 |
| Other current liabilities | 10,421 | 10,306 | 12,767 | 10,123 | 7,124 |
| TOTAL | $58,693 | $53,591 | $56,517 | $49,040 | $41,494 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,736 | 1,882 | 2,133 | 2,271 | N/A |
| Deferred Revenues | 23,047 | 20,612 | 18,104 | 12,986 | 12,093 |
| Other Non-Current Liabilities | 28,519 | 29,348 | 29,453 | 29,306 | 30,925 |
| TOTAL | $45,213 | $47,284 | $44,598 | $44,890 | $41,292 |
| Total Liabilities | $103,906 | $100,875 | $101,115 | $93,930 | $82,786 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 135,549 | 136,360 | 135,667 | 135,431 | 134,853 |
| Common Shares | 136 | 136 | 136 | 135 | 135 |
| Retained earnings | -34,681 | -28,225 | -23,837 | -17,030 | -20,559 |
| Other shareholders' equity | -1,579 | -1,759 | -587 | -446 | -468 |
| TOTAL | $415,524 | $424,179 | $423,460 | $425,546 | $416,509 |
| Total Liabilities And Equity | $519,430 | $525,054 | $524,575 | $519,476 | $499,295 |